Foundry Partners, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$815,000
-15.9%
8,550
-1.3%
0.04%
-17.0%
Q2 2020$969,000
+48.2%
8,660
-3.7%
0.05%
+27.0%
Q1 2020$654,000
-30.2%
8,9890.0%0.04%
+5.7%
Q4 2019$937,000
+2.3%
8,989
-2.3%
0.04%
-7.9%
Q3 2019$916,000
-13.0%
9,203
-0.2%
0.04%
-7.3%
Q2 2019$1,053,000
-9.5%
9,224
-0.3%
0.04%
-12.8%
Q1 2019$1,163,000
+11.1%
9,251
+19.8%
0.05%
+113.6%
Q4 2018$1,047,0007,7190.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders